Bioxcel Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.41

+0.01 (+0.71%)

As of Jun 30, 10:44 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 82%

Hold 1 9%

Sell 1 9%

Price Target

Analyst Price Target +1,457.4% upside

Low Target $14.05

Average Target $21.96

High Target $26.87

Current Price $1.41

Current
$1.41

Target
$21.96

$14.05 $21.96 avg $26.87

Scenario Analysis

Bear Case

$14.05

896.5%

Low target

Base Case

$21.96

+1,457.4%

Avg target

Bull Case

$26.87

+1,805.7%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$8.08

-82.5% from high

52-Week Low

$1.01

+39.6% from low

Target vs 52W High

$21.96

+171.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%